MPM Capital

presented by
presented by

Vascular Pharmaceuticals announces $9M expansion of Series A financing

The mission to move forward with addressing complications for diabetic patients, specifically diabetic nephropathy that leads to kidney disease, continues Tuesday with an increase in Series A funding (a $9 million addition that brings the total to $25 million) for the clinical-stage pharmaceutical company Vascular Pharmaceuticals, Inc. (VPI). According to a press release, existing investors […]

Novartis buys cancer immunotherapy startup co-founded by venture investors

A biotechnology company formed by two MPM Capital managing directors to develop monoclonal antibody drugs to fight cancer has been acquired by Novartis, according to a company statement. The move follows Novartis’ deal with University of Pennsylvania to collaborate on chimeric antigen receptor technology and reflects a relatively dramatic shift in the past year toward […]